COH Share Price

Open 131.98 Change Price %
High 133.52 1 Day 2.10 1.60
Low 131.39 1 Week 1.19 0.90
Close 133.25 1 Month 3.05 2.34
Volume 156473 1 Year 31.55 31.02
52 Week High 144.12
52 Week Low 99.11
COH Important Levels
Resistance 2 135.22
Resistance 1 134.41
Pivot 132.72
Support 1 132.09
Support 2 131.28
ASX Australia Most Active Stocks
BUR 0.02 0.00%
BUR 0.02 0.00%
BUR 0.02 0.00%
AGO 0.03 0.00%
AGO 0.03 0.00%
AGO 0.03 0.00%
KEY 0.01 0.00%
KEY 0.01 0.00%
KEY 0.01 0.00%
KEY 0.01 0.00%
More..
ASX Australia Top Gainers Stocks
KSO 0.40 3900.00%
IRM 0.03 50.00%
IRM 0.03 50.00%
IRM 0.03 50.00%
GBG 0.03 50.00%
GBG 0.03 50.00%
GBG 0.03 50.00%
BNV 0.03 50.00%
PMQ 0.03 50.00%
ANP 0.04 33.33%
More..
ASX Australia Top Losers Stocks
APP 0.20 -80.00%
APP 0.20 -80.00%
APP 0.20 -80.00%
APP 0.20 -80.00%
TCQ 0.27 -73.53%
XST 0.01 -50.00%
XST 0.01 -50.00%
GDY 0.01 -50.00%
RDS 0.02 -33.33%
RDS 0.02 -33.33%
More..

Cochlear Ltd (ASX: COH)

COH Technical Analysis 4
As on 24th Mar 2017 COH Share Price closed @ 133.25 and we RECOMMEND Buy for LONG-TERM with Stoploss of 127.02 & Strong Buy for SHORT-TERM with Stoploss of 129.67 we also expect STOCK to react on Following IMPORTANT LEVELS.
COH Target for March
1st Target up-side 136.62
2nd Target up-side 140.88
3rd Target up-side 145.13
1st Target down-side 124.48
2nd Target down-side 120.22
3rd Target down-side 115.97
COH Other Details
Segment EQ
Market Capital 0.00
Sector Healthcare
Industry Medical Appliances & Equipment
Offical website http://www.cochlear.com
COH Address
COH
1 University Avenue
Macquarie University, NSW 2109
Australia
Phone: 61 2 9428 6555
Fax: 61 2 9428 6352
COH Latest News
Interactive Technical Analysis Chart Cochlear Ltd ( COH ASX Australia )
Java support must be enabled in order to display FnCharts.
You can download Java from http://www.java.com
Your Comments and Response on Cochlear Ltd
COH Business Profile
Cochlear Limited provides implantable hearing solutions. It offers the Cochlear Nucleus range of cochlear implant systems; Baha bone conduction implants for treating conductive hearing loss, mixed hearing loss, and single-sided deafness; bone anchored prosthetics, such as the Cochlear Vistafix bone-anchored facial prosthetic solution to enhance the attachment and cosmetic outcome of facial prostheses; and support services. The company provides its products directly, as well as through distributors and agents in the United States, Canada, and Latin America; Europe, the Middle East, and Africa; and Australasia and Asia. Cochlear Limited is headquartered in Macquarie University, Australia.